14-16 October 2026
Lisbon, Portugal




Call for abstracts will open on 27 January 2026.

Apply for oral or poster presentations.


The Champalimaud Research Symposium 2026
(CRSy26) will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.

Key topics will include mechanistic insights into neuro-immune signaling pathways, the influence of stress and innervation on tumor immunity, and how immune responses can affect neural activity within tumours and beyond.


Symposium Chairs

Carlos Minutti
Immunoregulation Lab, Champalimaud Foundation, Lisbon, PT

Henrique Veiga-Fernandes Immunophysiology Lab, Champalimaud Foundation, Lisbon, PT


Confirmed Keynote Speakers

Douglas Hanahan
EPFL, Lausanne, CH

Florent Ginhoux
Gustave Roussy, Villejuif, FR

CRSy is the main scientific symposium of the Champalimaud Research. Since 2017, it has fostered global dialogue among researchers across various disciplines, focusing on groundbreaking advancements in neuroscience, physiology and cancer.


Previous Editions

2024
2022



︎    ︎    ︎    

Eva Dyer, PhD


University of Pennsylvania

Philadelphia, Pennsylvania, USA

Dyer’s research interests lie at the intersection of machine learning, optimization, and neuroscience. Her lab develops computational methods for discovering principles that govern the organization and structure of the brain, as well as methods for integrating multi-modal datasets to reveal the link between neural structure and function.

︎ Visit the speaker’s lab here